Myriad Genetics (MYGN) Cash Flow: Operating & Free Cash Flow

Myriad Genetics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Myriad Genetics, Inc. (MYGN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Jun 2020	Jun 2019	Jun 2018
Operating Activities
Net Income	-365.90	-127.30	-263.30	-112.00	-27.20	-223.70	-199.50	4.60
Depreciation & Amortization	53.70	61.20	61.90	52.70	62.80	71.40	72.00	73.00
Deferred Income Tax	-32.40	-0.30	-0.60	-31.90	-34.70	-54.50	-54.10	13.10
Stock Based Compensation	35.20	49.80	40.70	38.10	36.30	24.30	25.20	33.50
Change in Working Capital	-19.30	-54.40	27.00	-101.50	120.80	30.20	117.90	-39.40
Change in Accounts Receivable	6.20	-8.70	-12.50	7.70	-8.80	28.90	64.00	-18.20
Change in Inventory	-3.20	-6.20	-1.80	-2.90	1.60	1.30	1.60	8.00
Change in Accounts Payable	-1.40	4.70	-3.70	-3.50	9.20	0.00	-10.70	1.10
Change in Other Working Capital	11.10	-44.20	17.10	31.40	118.80	0.00	63.00	-30.30
Other Operating Activities	11.10	62.30	79.40	31.40	-139.40	125.40	99.20	-1.10
Net Cash from Operating Activities	1.80	-8.70	-110.90	-106.30	18.60	-26.90	60.70	83.70
Investing Activities
Capital Expenditures	-27.40	-29.70	-63.20	-45.30	-18.00	-13.20	-10.20	-8.60
Acquisitions	0.00	8.80	0.00	-57.20	379.10	0.00	21.30	-278.50
Purchases of Investments	0.00	0.00	105.20	-103.20	-147.80	0.00	-60.80	-78.50
Sales/Maturities of Investments	0.00	9.00	105.20	128.20	61.10	0.00	69.00	79.20
Other Investing Activities	-27.40	0.00	0.00	0.00	0.00	74.80	0.00	0.00
Net Cash from Investing Activities	-27.40	-11.90	31.90	-77.50	274.40	61.60	19.30	-286.40
Financing Activities
Debt Repayment	-80.70	0.10	-40.20	0.00	-226.40	0.00	-8.60	225.00
Common Stock Issued	3.30	0.00	123.60	6.30	91.80	0.00	0.00	0.00
Common Stock Repurchased	-7.30	0.00	-8.80	0.00	0.00	0.00	0.00	-50.00
Other Financing Activities	-23.40	-7.50	-1.90	-14.30	-16.00	-1.00	-1.40	7.30
Net Cash from Financing Activities	64.20	-7.40	152.90	-8.00	-150.60	-1.00	-10.00	182.30
Summary
Effect of Forex Changes on Cash	0.80	-1.00	0.60	-0.60	-0.60	0.60	0.50	2.70
Net Change in Cash	39.40	-29.00	74.50	-192.40	141.80	70.50	70.50	-17.70
Cash at Beginning of Period	111.90	140.90	66.40	258.80	117.00	93.20	93.20	110.90
Cash at End of Period	151.30	111.90	140.90	66.40	258.80	163.70	163.70	93.20
Free Cash Flow	-25.60	-38.40	-174.10	-151.60	0.60	-40.10	50.50	75.10
Supplemental Disclosures
Interest Paid	-	1.90	1.40	-	4.40	-	-	-
Income Taxes Paid	-	2.70	1.90	1.80	-85.40	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Myriad Genetics Cash Flow

What is Myriad Genetics's free cash flow?

Myriad Genetics had negative free cash flow of $25.60M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $1.80M minus $27.40M of capital expenditures.

How much does Myriad Genetics spend on capital expenditures?

Myriad Genetics spent $27.40M on capital expenditures in fiscal 2025, compared with $29.70M a year earlier. That equals 1522.2% of operating cash flow.

Does Myriad Genetics pay dividends or buy back shares?

Yes. In fiscal 2025 Myriad Genetics returned $7.30M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition